Skip to main content
Cardiovascular Diseases logoLink to Cardiovascular Diseases
. 1976;3(3):249–288.

AN INTRACORPOREAL (ABDOMINAL) LEFT VENTRICULAR ASSIST DEVICE [ALVAD], XXX: CLINICAL READINESS AND INITIAL TRIALS IN MAN

John C Norman 1
PMCID: PMC287607  PMID: 15216148

Abstract

The purpose of this report is to present documenting evidence of the clinical readiness of an abdominal left ventricular assist device (ALVAD) according to NHLI criteria, and the initiation of clinical trials of this device in otherwise irretrievable adult post-cardiotomy patients at the Texas Heart Institute of St. Luke's Episcopal and Texas Children's Hospitals. The ALVAD system has been developed, modified, and improved under NHLI auspices over the last eight years,‡‡ with annual reviews. Over 20,000 hours of in-vivo testing in the calf have been accomplished in our laboratories. The current clinical trials underwent two federal reviews (May 22, 1973 and October 17, 1974) and were the topic of an Ad Hoc Workshop at NHLI on October 28, 1973.‡‡‡ More recently, a consecutive series of 26 bovine ALVAD implantations were undertaken; acute and chronic hemodynamic effectiveness with maintenance or augmentation of the systemic circulation during profound ventricular unloading without undue blood trauma, intra-or extra-prosthetic thrombosis, or sepsis was demonstrated; no biomaterials problems were encountered. In-vivo realibility and durability, histologic and pathologic results were detailed, summarized, and submitted to NHLI. Patient acceptability surveys and geometric and volumetric human configuration studies were analyzed. Categorizations of the patients at risk in our institutions and the needs for such a device were documented. The periods of intended use (two weeks-one month), weaning procedures, and the possibility of pump dependence have been discussed. The legal, moral, ethical and informed consent issues were addressed. Clinical protocols (anesthesia, surgical, cardiologic, hematologic, engineering, computerized data-acquisition, follow-up) and cost analyses were developed. The device has now been used in four terminal patients since December, 1975; all subsequently succumbed, but their circulations were temporarily supported during total left ventricular unloading for periods up to eight hours. Continued systematic, controlled clinical investigations of this nature are warranted. A comprehensive listing of pertinent references is included.

Full text

PDF
249

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carlos C. J., Edmonds C. H., Fuqua J. M., Hibbs C. W., Igo S. R., Nitta S., Norman J. C. Production of controlled reversible left ventricular failure in calves using intracoronary lidocaine hydrochloride: a useful method of evaluating left ventricular assist devices. Ann Thorac Surg. 1976 Mar;21(3):209–214. doi: 10.1016/s0003-4975(10)64293-2. [DOI] [PubMed] [Google Scholar]
  2. Hughes D. A., Igo S. R., Daly B. D., Migliore J. J., Norman J. C. Effects of an abdominal left ventricular assist device on myocardial oxygen supply/demand ratios in normally perfused and ischemic bovine myocardium. Ann Thorac Surg. 1975 Mar;19(3):301–308. doi: 10.1016/s0003-4975(10)64021-0. [DOI] [PubMed] [Google Scholar]
  3. Igo S. R., Migliore J. J., Fuqua J. M., Jr, Norman J. C. Effects of abdominal left ventricular assist device (ALVAD) on myocardial contractility during acute coronary occlusion. J Surg Res. 1974 Sep;17(3):177–185. doi: 10.1016/0022-4804(74)90105-x. [DOI] [PubMed] [Google Scholar]
  4. Naifeh J. G., Thompson P. A., Johnson M. D., Hibbs C. W., Fuqua J. M., Norman J. C. Performance of an abdominal left ventricular assist device during induced tachycardias and dysrhythmias. J Thorac Cardiovasc Surg. 1976 Aug;72(2):175–181. [PubMed] [Google Scholar]
  5. Norman John C. AN INTRACORPOREAL (ABDOMINAL) LEFT VENTRICULAR ASSIST DEVICE, XXII: Précis and State of the Art. Cardiovasc Dis. 1975;2(4):425–437. [PMC free article] [PubMed] [Google Scholar]
  6. Norman John C. An ABDOMINAL LEFT VENTRICULAR ASSIST DEVICE (ALVAD): PERSPECTIVES AND PROSPECTS. Cardiovasc Dis. 1974;1(3):251–264. [PMC free article] [PubMed] [Google Scholar]
  7. Norman John C., Bernhard William F. CRITERIA, PROTOCOLS AND REPORTING FORMS FOR INITIAL LEFT VENTRICULAR ASSIST DEVICE CLINICAL TRIALS. Cardiovasc Dis. 1975;2(4):438–445. [PMC free article] [PubMed] [Google Scholar]
  8. Robinson W. J., Benedict B. S., Daly D. T., Hughes D. A., Migliore J. J., Hibbs C. W., Igo S. R., Norman J. C. An abdominal left ventricular assist device: preclinical studies. Ann Thorac Surg. 1975 May;19(5):540–551. doi: 10.1016/s0003-4975(10)64430-x. [DOI] [PubMed] [Google Scholar]
  9. Robinson W. J., Igo S. R., Daly B. D., Migliore J. J., Hughes D. A., Edmonds C. H., Fuqua J. M., Jr, Huffman F. N., Norman J. C. An abdominal left ventricular assist device (ALVAD): chronic hemodynamic analyses in the calf. Trans Am Soc Artif Intern Organs. 1974;20 B:709–720. [PubMed] [Google Scholar]
  10. Robinson W. J., Migliore J. J., Arthur J., Fuqua J. M., Dove G. B., Coleman S., Huffman F. N., Norman J. C. An abdominal left ventricular assist device: experimental physiologic analyses. II. Trans Am Soc Artif Intern Organs. 1973;19:229–234. doi: 10.1097/00002480-197301900-00039. [DOI] [PubMed] [Google Scholar]

Articles from Cardiovascular Diseases are provided here courtesy of Texas Heart Institute

RESOURCES